SlidesetHIVEuropean HIV Clinical Forum 2019Long-Acting Parenteral Antiretroviral Regimens: Where Might They Fit? - Saye Khoo, MD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019Impact on transmitted and acquired drug resistance - Anne-Geneviève Marcelin, PharmD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019Single-Tablet Regimens Versus Multiple Pills: Is There a Meaningful Difference? - Bonaventura Clotet, MD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019New Treatments and Treatment Paradigms - Sharon Walmsley, FRCPC, MD, MSCView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019Oral Versus Injectable PrEP - Saye Khoo, MD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019Update on PrEP use in Europe - Ann Sullivan, MBBS, DIPGUM, DFFP, MD, FRCPView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019When to start antiretroviral therapy after diagnosis – trade-offs and considerations - Anton Pozniak, MD, FRCPView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019First line regimens in different European countries 2019 – an overview - Miłosz Parczewski, MD, PhDView Slideset
SlidesetHIVEuropean HIV Clinical Forum 2019Second generation INSTI regimens for drug naive patients: State of the Art - Daniel Kuritzkes, MDView Slideset
SlidesetHIVInternational Workshop on HIV Pediatrics 2020SARS-Cov-2 Vaccines - Anthony FauciView Slideset
